regonix slider
regonix slider 2
regonix slider 1


Neratinib is indicated for the extended adjuvant treatment of adult patients with early stage
HER2-overexpressed/amplified breast cancer, to follow adjuvant trastuzumab based therapy.

Beacon Introduces Global Patient Support Program

Life saving drugs are either beyond the reach of general people or not available in many countries. Because of the patient exemptions for Bangladeshi companies,Beacon Pharmaceuticals can manufacture the patented drugs. As a support to global patient.

Read More

Registered and Licensed by Regulatory Authority of Bangladesh

Hernix is a registered product by the Directorate General of Drug Administration & Licensing Authority (Drugs) of Bangladesh. Drug Registration Number: 341-361-010 Inclusion Date: 00-00-0000 Valid up to: 00-00-0000

Read More

Global Scarcity of Life Saving Drugs- A Shocking Epidemic

Beacon: Ready to Meet your Needs